Ryan Specialty (NYSE:RYAN) Shares Down 4.3% – Time to Sell?

Ryan Specialty Holdings Inc. (NYSE:RYAN)’s stock price dropped 4.3% on Wednesday . The stock traded as low as $50.62 and last traded at $49.9620. Approximately 106,045 shares changed hands during trading, a decline of 91% from the average daily volume of 1,231,194 shares. The stock had previously closed at $52.19.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. The Goldman Sachs Group set a $61.00 price objective on Ryan Specialty in a research report on Wednesday, January 7th. Wells Fargo & Company upped their price objective on Ryan Specialty from $61.00 to $63.00 and gave the company an “overweight” rating in a research report on Tuesday, January 13th. Barclays dropped their price objective on Ryan Specialty from $65.00 to $58.00 and set an “overweight” rating for the company in a research report on Thursday, January 8th. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. Finally, UBS Group lowered their price target on shares of Ryan Specialty from $80.00 to $75.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $64.19.

Ryan Specialty Trading Down 3.8%

The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 2.72. The stock has a market capitalization of $13.25 billion, a price-to-earnings ratio of 109.27, a price-to-earnings-growth ratio of 1.30 and a beta of 0.63. The business has a 50 day simple moving average of $53.86 and a 200-day simple moving average of $56.24.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings data on Thursday, October 30th. The company reported $0.47 earnings per share for the quarter, hitting the consensus estimate of $0.47. Ryan Specialty had a net margin of 7.61% and a return on equity of 47.93%. The business had revenue of $754.58 million for the quarter, compared to analyst estimates of $742.35 million. During the same period in the prior year, the firm posted $0.41 EPS. The company’s revenue was up 24.8% on a year-over-year basis. On average, equities analysts predict that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Tuesday, November 11th were issued a $0.12 dividend. The ex-dividend date was Monday, November 10th. This represents a $0.48 dividend on an annualized basis and a yield of 1.0%. Ryan Specialty’s dividend payout ratio (DPR) is presently 104.35%.

Insider Activity at Ryan Specialty

In other news, CEO Timothy William Turner sold 129,570 shares of Ryan Specialty stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the transaction, the chief executive officer directly owned 12,553 shares of the company’s stock, valued at $672,966.33. The trade was a 91.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 52.21% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of hedge funds have recently made changes to their positions in the business. Allspring Global Investments Holdings LLC acquired a new stake in shares of Ryan Specialty in the 2nd quarter valued at about $37,321,000. Sumitomo Mitsui Trust Group Inc. raised its stake in Ryan Specialty by 2.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,387,108 shares of the company’s stock valued at $78,177,000 after buying an additional 33,588 shares in the last quarter. Cooper Investors PTY Ltd. raised its stake in Ryan Specialty by 33.9% during the third quarter. Cooper Investors PTY Ltd. now owns 505,374 shares of the company’s stock valued at $28,483,000 after buying an additional 127,892 shares in the last quarter. Marshall Wace LLP lifted its holdings in Ryan Specialty by 142.1% during the 2nd quarter. Marshall Wace LLP now owns 380,116 shares of the company’s stock worth $25,844,000 after buying an additional 223,124 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its position in shares of Ryan Specialty by 56.0% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 68,671 shares of the company’s stock worth $3,870,000 after acquiring an additional 24,656 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.